LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets

Takashi Kenmochi, Masaaki Miyamoto, Hiroyuki Sasaki, Satoshi Une, Yoshihiko Nakagawa, Stefan Moldovan, Pierre Y. Benhamou, F. Charles Brunicardi, Hisako Tanaka, Yoko Mullen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The most critical factors that affect the outcome of clinical pancreatic islet transplantation are the number and quality of donor islets available for transplantation. Toward this goal, we attempted to obtain islets that are both of better quality and higher number than are obtainable by the islet- isolation process that is now widely used. We paid special attention to two critical components of the isolation procedure: minimizing the exposure of pancreatic tissue and freed islets to warm enzyme solution, and development of a preservation solution suitable for islets during cold storage of digested pancreatic tissue-free islets. For this purpose, we developed both a two-step procedure for pancreas digestion and a new cold preservation solution, the LAP-1 solution (Los Angeles preservation solution 1). In this study, we evaluated the effect of four preservation solutions by storing digested pancreatic tissues on ice for 90 min. After the cold storage, islets were purified on three layers of Euro-Ficoll solutions in a 50-ml tube, and the islet yield, viability, and function were determined. These experiments were performed by using samples from 10 consecutive islet isolations. Results with LAP-1, original University of Wisconsin solution (oUW), and modified UW solution (mUW; UW without hydroxyethyl starch) were compared with those obtained with Hank's balanced salt solution (HBSS). The islet yield was significantly higher in the LAP-1 and mUW groups as compared with the HBSS group (p < 0.01). The islet purity was significantly better in the LAP-1, oUW, and mUW groups than the HBSS (p < 0.001). The islet viability was lowest in the HBSS group immediately after purification (vs. LAP-1, oUW, and mUW, p < 0.05) and further decreased during culture (p < 0.01). Both the number and viability of cultured islets were the highest with LAP- 1 solution but without statistical significance between mUW and oUW. Electron microscopic examination showed only slight damage to cell membranes immediately after purification of islets stored in LAPel solution and their complete recovery within 1-2 days of culture. These islets also exhibited normal insulin responses to high glucose by static incubation and perifusion assays.

Original languageEnglish
Pages (from-to)367-377
Number of pages11
JournalPancreas
Volume17
Issue number4
DOIs
Publication statusPublished - 01-01-1998
Externally publishedYes

Fingerprint

Islets of Langerhans
Salts
Islets of Langerhans Transplantation
Ficoll
Los Angeles
Ice
Starch
Pancreas
Digestion

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Kenmochi, T., Miyamoto, M., Sasaki, H., Une, S., Nakagawa, Y., Moldovan, S., ... Mullen, Y. (1998). LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets. Pancreas, 17(4), 367-377. https://doi.org/10.1097/00006676-199811000-00007
Kenmochi, Takashi ; Miyamoto, Masaaki ; Sasaki, Hiroyuki ; Une, Satoshi ; Nakagawa, Yoshihiko ; Moldovan, Stefan ; Benhamou, Pierre Y. ; Brunicardi, F. Charles ; Tanaka, Hisako ; Mullen, Yoko. / LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets. In: Pancreas. 1998 ; Vol. 17, No. 4. pp. 367-377.
@article{d726a768e468410897530225960dbeb6,
title = "LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets",
abstract = "The most critical factors that affect the outcome of clinical pancreatic islet transplantation are the number and quality of donor islets available for transplantation. Toward this goal, we attempted to obtain islets that are both of better quality and higher number than are obtainable by the islet- isolation process that is now widely used. We paid special attention to two critical components of the isolation procedure: minimizing the exposure of pancreatic tissue and freed islets to warm enzyme solution, and development of a preservation solution suitable for islets during cold storage of digested pancreatic tissue-free islets. For this purpose, we developed both a two-step procedure for pancreas digestion and a new cold preservation solution, the LAP-1 solution (Los Angeles preservation solution 1). In this study, we evaluated the effect of four preservation solutions by storing digested pancreatic tissues on ice for 90 min. After the cold storage, islets were purified on three layers of Euro-Ficoll solutions in a 50-ml tube, and the islet yield, viability, and function were determined. These experiments were performed by using samples from 10 consecutive islet isolations. Results with LAP-1, original University of Wisconsin solution (oUW), and modified UW solution (mUW; UW without hydroxyethyl starch) were compared with those obtained with Hank's balanced salt solution (HBSS). The islet yield was significantly higher in the LAP-1 and mUW groups as compared with the HBSS group (p < 0.01). The islet purity was significantly better in the LAP-1, oUW, and mUW groups than the HBSS (p < 0.001). The islet viability was lowest in the HBSS group immediately after purification (vs. LAP-1, oUW, and mUW, p < 0.05) and further decreased during culture (p < 0.01). Both the number and viability of cultured islets were the highest with LAP- 1 solution but without statistical significance between mUW and oUW. Electron microscopic examination showed only slight damage to cell membranes immediately after purification of islets stored in LAPel solution and their complete recovery within 1-2 days of culture. These islets also exhibited normal insulin responses to high glucose by static incubation and perifusion assays.",
author = "Takashi Kenmochi and Masaaki Miyamoto and Hiroyuki Sasaki and Satoshi Une and Yoshihiko Nakagawa and Stefan Moldovan and Benhamou, {Pierre Y.} and Brunicardi, {F. Charles} and Hisako Tanaka and Yoko Mullen",
year = "1998",
month = "1",
day = "1",
doi = "10.1097/00006676-199811000-00007",
language = "English",
volume = "17",
pages = "367--377",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Kenmochi, T, Miyamoto, M, Sasaki, H, Une, S, Nakagawa, Y, Moldovan, S, Benhamou, PY, Brunicardi, FC, Tanaka, H & Mullen, Y 1998, 'LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets', Pancreas, vol. 17, no. 4, pp. 367-377. https://doi.org/10.1097/00006676-199811000-00007

LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets. / Kenmochi, Takashi; Miyamoto, Masaaki; Sasaki, Hiroyuki; Une, Satoshi; Nakagawa, Yoshihiko; Moldovan, Stefan; Benhamou, Pierre Y.; Brunicardi, F. Charles; Tanaka, Hisako; Mullen, Yoko.

In: Pancreas, Vol. 17, No. 4, 01.01.1998, p. 367-377.

Research output: Contribution to journalArticle

TY - JOUR

T1 - LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets

AU - Kenmochi, Takashi

AU - Miyamoto, Masaaki

AU - Sasaki, Hiroyuki

AU - Une, Satoshi

AU - Nakagawa, Yoshihiko

AU - Moldovan, Stefan

AU - Benhamou, Pierre Y.

AU - Brunicardi, F. Charles

AU - Tanaka, Hisako

AU - Mullen, Yoko

PY - 1998/1/1

Y1 - 1998/1/1

N2 - The most critical factors that affect the outcome of clinical pancreatic islet transplantation are the number and quality of donor islets available for transplantation. Toward this goal, we attempted to obtain islets that are both of better quality and higher number than are obtainable by the islet- isolation process that is now widely used. We paid special attention to two critical components of the isolation procedure: minimizing the exposure of pancreatic tissue and freed islets to warm enzyme solution, and development of a preservation solution suitable for islets during cold storage of digested pancreatic tissue-free islets. For this purpose, we developed both a two-step procedure for pancreas digestion and a new cold preservation solution, the LAP-1 solution (Los Angeles preservation solution 1). In this study, we evaluated the effect of four preservation solutions by storing digested pancreatic tissues on ice for 90 min. After the cold storage, islets were purified on three layers of Euro-Ficoll solutions in a 50-ml tube, and the islet yield, viability, and function were determined. These experiments were performed by using samples from 10 consecutive islet isolations. Results with LAP-1, original University of Wisconsin solution (oUW), and modified UW solution (mUW; UW without hydroxyethyl starch) were compared with those obtained with Hank's balanced salt solution (HBSS). The islet yield was significantly higher in the LAP-1 and mUW groups as compared with the HBSS group (p < 0.01). The islet purity was significantly better in the LAP-1, oUW, and mUW groups than the HBSS (p < 0.001). The islet viability was lowest in the HBSS group immediately after purification (vs. LAP-1, oUW, and mUW, p < 0.05) and further decreased during culture (p < 0.01). Both the number and viability of cultured islets were the highest with LAP- 1 solution but without statistical significance between mUW and oUW. Electron microscopic examination showed only slight damage to cell membranes immediately after purification of islets stored in LAPel solution and their complete recovery within 1-2 days of culture. These islets also exhibited normal insulin responses to high glucose by static incubation and perifusion assays.

AB - The most critical factors that affect the outcome of clinical pancreatic islet transplantation are the number and quality of donor islets available for transplantation. Toward this goal, we attempted to obtain islets that are both of better quality and higher number than are obtainable by the islet- isolation process that is now widely used. We paid special attention to two critical components of the isolation procedure: minimizing the exposure of pancreatic tissue and freed islets to warm enzyme solution, and development of a preservation solution suitable for islets during cold storage of digested pancreatic tissue-free islets. For this purpose, we developed both a two-step procedure for pancreas digestion and a new cold preservation solution, the LAP-1 solution (Los Angeles preservation solution 1). In this study, we evaluated the effect of four preservation solutions by storing digested pancreatic tissues on ice for 90 min. After the cold storage, islets were purified on three layers of Euro-Ficoll solutions in a 50-ml tube, and the islet yield, viability, and function were determined. These experiments were performed by using samples from 10 consecutive islet isolations. Results with LAP-1, original University of Wisconsin solution (oUW), and modified UW solution (mUW; UW without hydroxyethyl starch) were compared with those obtained with Hank's balanced salt solution (HBSS). The islet yield was significantly higher in the LAP-1 and mUW groups as compared with the HBSS group (p < 0.01). The islet purity was significantly better in the LAP-1, oUW, and mUW groups than the HBSS (p < 0.001). The islet viability was lowest in the HBSS group immediately after purification (vs. LAP-1, oUW, and mUW, p < 0.05) and further decreased during culture (p < 0.01). Both the number and viability of cultured islets were the highest with LAP- 1 solution but without statistical significance between mUW and oUW. Electron microscopic examination showed only slight damage to cell membranes immediately after purification of islets stored in LAPel solution and their complete recovery within 1-2 days of culture. These islets also exhibited normal insulin responses to high glucose by static incubation and perifusion assays.

UR - http://www.scopus.com/inward/record.url?scp=0031738293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031738293&partnerID=8YFLogxK

U2 - 10.1097/00006676-199811000-00007

DO - 10.1097/00006676-199811000-00007

M3 - Article

C2 - 9821178

AN - SCOPUS:0031738293

VL - 17

SP - 367

EP - 377

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 4

ER -